Cosmas Pharmacls Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 11.00 Cr
as on 15-11-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 52.03 Cr
as on 15-11-2024
- Satisfied Charges ₹ 1.58 Cr
as on 15-11-2024
- Revenue 10.81%
(FY 2023)
- Profit 90.62%
(FY 2023)
- Ebitda 99.04%
(FY 2023)
- Net Worth -2.17%
(FY 2023)
- Total Assets -9.52%
(FY 2023)
About Cosmas Pharmacls
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 11.00 Cr.
The company currently has active open charges totaling ₹52.03 Cr. The company has closed loans amounting to ₹1.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
Punit Jain, Sanjay Jain, Tanuj Jain, and Six other members serve as directors at the Company.
- CIN/LLPIN
U24232PB2010PLC033534
- Company No.
033534
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cosmas Pharmacls Limited offer?
Cosmas Pharmacls Limited offers a wide range of products and services, including Protective Packing Materials, Pharmaceutical Packaging Tray, Common Disease Medicines, Injectable Products, Pharmaceutical Medicine, Pharmaceutical Products.
Who are the key members and board of directors at Cosmas Pharmacls?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Punit Jain  | Managing Director | 22-Jan-2010 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Jain | Whole-Time Director | 22-Jan-2010 | Current |
| Tanuj Jain | Whole-Time Director | 22-Jan-2010 | Current |
| Tilak Bhardwaj | Director | 24-Mar-2010 | Current |
| Tapan Pal | Director | 24-Mar-2010 | Current |
| Ram Garg | Director | 07-Apr-2010 | Current |
| Parkash Chopra | Director | 13-Apr-2010 | Current |
Financial Performance of Cosmas Pharmacls.
Cosmas Pharmacls Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.81% increase. The company also saw a substantial improvement in profitability, with a 90.62% increase in profit. The company's net worth dipped by a decrease of 2.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cosmas Pharmacls?
In 2023, Cosmas Pharmacls had a promoter holding of 97.27% and a public holding of 2.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cosmas Research Lab LimitedActive 16 years 7 monthsPunit Jain, Sanjay Jain and 2 more are mutual person
Armour Remedies India LimitedActive 21 years 7 monthsPunit Jain, Sanjay Jain and 2 more are mutual person
- Cruise Pharmacia Private LimitedActive 17 years 2 months
Punit Jain, Sanjay Jain and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Apr 2011 | ₹14.27 Cr | Open |
Others Creation Date: 03 Feb 2011 | ₹14.27 Cr | Open |
Punjab National Bank Creation Date: 11 Jun 2010 | ₹3.00 Cr | Open |
How Many Employees Work at Cosmas Pharmacls?
Cosmas Pharmacls has a workforce of 7 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmas Pharmacls, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmas Pharmacls's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
